A detailed history of Syon Capital LLC transactions in Incyte Corp stock. As of the latest transaction made, Syon Capital LLC holds 4,992 shares of INCY stock, worth $302,515. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,992
Previous 3,977 25.52%
Holding current value
$302,515
Previous $263 Million 31.16%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.08 - $83.38 $66,056 - $84,630
1,015 Added 25.52%
4,992 $345 Million
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $2,063 - $2,469
-36 Reduced 0.9%
3,977 $263 Million
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $1,996 - $2,486
39 Added 0.98%
4,013 $243 Million
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $6,163 - $7,258
109 Added 2.82%
3,974 $226 Million
Q4 2023

Feb 02, 2024

BUY
$52.16 - $64.19 $201,598 - $248,094
3,865 New
3,865 $243 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.